Evidence map›Paper›PMID 24735711›Full record

ReviewThe international journal of biochemistry & cell biology2014

C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.

Su Hao Lo

Abstract readReview
In one paragraph

Review in The international journal of biochemistry & cell biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Tensins in Kidney Function and Diseases.Life (Basel, Switzerland) · 2023
    Review
  7. The role of tensins in malignant neoplasms.Archives of medical science : AMS · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Frontiers in bioengineering and biotechnology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Force-induced recruitment of cten along keratin network in epithelial cells.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Su Hao LoDepartment of Biochemistry and Molecular Medicine, University of California-Davis, Sacramento, CA 95817, United States. Electronic address: shlo@ucdavis.edu.
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Role of Cten in Prostate CancerR01CA102537 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI LO, SU HAO · 2004 to 2016
$2.4M
Mechanism of DLC1-mediated tumor suppressionR01CA151366 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LO, SU HAO · 2010 to 2014
$1.5M
Role of Cten in Prostate CancerR56CA102537 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LO, SU HAO · 2009 to 2009
$240k
NCI NIH HHS CA102537NCI NIH HHS CA151366NCI NIH HHS P30 CA093373NCI NIH HHS R01 CA102537NCI NIH HHS R01 CA151366NCI NIH HHS R56 CA102537
6 · The paper itself

Abstract

C-terminal tensin-like (cten, also known as tensin4, TNS4) is a member of the tensin family. Cten protein, like the other three tensin family members, localizes to focal adhesion sites but only shares sequence homology with other tensins at its C-terminal region, which contains the SH2 and PTB domains. Cten is abundantly expressed in normal prostate and placenta and is down-regulated in prostate cancer. However, overexpression of cten frequently associates with tumors derived from breast, colon, lung, stomach, skin and pancreas. A variety of cancer-associated growth factors and cytokines induce cten expression. Up-regulated cten promotes cell motility, prolongs epidermal growth factor receptor signaling, and enhances tumorigenicity. Emerging findings suggest that cten is a promising biomarker and therapeutic target for various cancers.

Indexed as

AnimalsBiomarkers, TumorFocal AdhesionsHumansMicrofilament ProteinsNeoplasmsSignal TransductionTensinsBiomarkers, TumorMicrofilament ProteinsTensinsTNS4 protein, humanCtenFocal adhesionTensinTumor promoterTumor suppressor

Identifiers

PMID24735711
PMCPMC4038153
OpenAlexW2015893880

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.